In vitro farnesylation

LE Leonidas Emmanouilidis
US Ulrike Schütz
KT Konstantinos Tripsianes
TM Tobias Madl
JR Juliane Radke
RR Robert Rucktäschel
MW Matthias Wilmanns
WS Wolfgang Schliebs
RE Ralf Erdmann
MS Michael Sattler
request Request a Protocol
ask Ask a question
Favorite

In vitro farnesylation assays were carried out as described29,30 in 50 mM Tris–HCl, pH 8.0, 20 mM KCl, 5 mM MgCl2, 10 μM ZnCl2 and 10 mM dithiothreitol. A reaction volume of 10 ml with 100 μM PEX19 was incubated with 130 μM farnesyl pyrophosphate (Sigma Aldrich) and 250 nM farnesyl transferase for 1 h at 37 °C. A subsequent Ni2+ affinity chromatography (nickel-nitrilotriacetic acid) removed the FTase. The farnesylated PEX19 was further purified by size exclusion chromatography on a HiLoad 16/60 Superdex 75 (GE Healthcare) and stored in 20 mM potassium phosphate, pH 6.5 and 50 mM NaCl. The completeness of the farnesylation was analysed by SDS gel electrophoresis and 1H,15N HSQC NMR spectra.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A